Clinical Trial Update: Pilot Assessment of Lopinavir/Ritonavir and Maraviroc [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating Lopinavir/ritonavir with Maraviroc in HIV/AIDS patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)
• Selzentry (Maraviroc)

Snippet

Sponsor: Rodwick, Barry M., M.D. | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | Phase 4 | Status: TERMINATED